|
|
||||||||
Department of Anesthesiology and Intensive Care, Sapienza University of Rome, Viale del Policlinico 155, Rome, 00161 Italy
(Email: vincenzo.desantis@uniroma1.it).
| The first 20% of the full text of this article appears below. |
To the Editor:
We appreciated the article by Bowman and colleagues [1]. The authors demonstrated that rescue therapy with recombinant human activated factor VII (rFVIIa) is effective in reducing transfusion requirements, correcting coagulopathy, and controlling of life-threatening bleeding in patients undergoing high-risk cardiovascular surgery. The majority of
Related Article
Ann. Thorac. Surg. 2008 86: 2025.
This article has been cited by other articles:
![]() |
J. S. Ikonomidis, W. Uber, and M. Stroud Reply. Ann. Thorac. Surg., December 1, 2008; 86(6): 2025 - 2025. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |